{"product_id":"scripps-5th-annual-scripps","title":"Scripps 5th Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium 2022","description":"\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003eScripps 5th Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium 2022 The Scripps Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state‐of‐the‐art, comprehensive, case‐based curriculum that addresses important clinical topics relevant to  cardiomyopathy and cardiovascular health of cancer survivors.\u003c\/div\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003e\u003c\/div\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003eCardio‐oncology is a growing field that has great importance as newly developed cancer treatments improve cancer survival rates but can be associated with cardiovascular  toxicities. Similarly, cardiac amyloidosis is a burgeoning disease with exciting new treatments.\u003c\/div\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003e\u003c\/div\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003eThe program is intended for those involved in the care of patients with cardiomyopathies, diastolic heart failure, chemotherapy or radiation induced heart disease, and cardiomyopathy related arrhythmic diseases. Nationally recognized faculty will use case‐based discussion to cover challenging heart failure topics related to common cardiomyopathies. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Include: 18 videos, size: 1.87 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: cardiologist, oncologist\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eBest Practices in Managing Cardiac Toxicity in the Breast Cancer Patient The Cardiologist’s Perspective-Margot Davis, MD, MSc.mp4\u003c\/li\u003e\n\u003cli\u003eBest Practices in Managing Cardiac Toxicity in the Breast Cancer Patient The Oncologist’s Perspective-Carrie Costantini, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCancer Survivorship How to Monitor for Cardiac Disease Following Treatment-Ann Kuo, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCardiac Sarcoidosis Making the Diagnosis, An Imaging Primer-Ajay Srivastava, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCardiac Sarcoidosis Who and How to Treat-Sumeet Mitter, MD.mp4\u003c\/li\u003e\n\u003cli\u003eClinical Presentation of Cardiac Amyloid Who Should We Suspect-Rajeev Mohan, MD.mp4\u003c\/li\u003e\n\u003cli\u003eContemporary Management of AL Amyloidosis-Anuj Mahindra, MD.mp4\u003c\/li\u003e\n\u003cli\u003eHow to Make the Diagnosis of Cardiac Amyloid-Rola Khedraki, MD.mp4\u003c\/li\u003e\n\u003cli\u003eManaging End-Stage Heart Failure in the Cancer Survivor-Brian Hardaway, MD.mp4\u003c\/li\u003e\n\u003cli\u003eManaging Venous Thromboembolic Disease in the Cancer Patient-Scott Cameron, MD, PhD.mp4\u003c\/li\u003e\n\u003cli\u003eMulti-Modality Imaging in Cardio-Oncology-Ballaji Tamarappoo, MD, PhD.mp4\u003c\/li\u003e\n\u003cli\u003ePharmacogenomics in Heart Failure-David Lanfear, MD, MS.mp4\u003c\/li\u003e\n\u003cli\u003eQ\u0026amp;A Panel Discussion-Carrie Costantini, MD, Margot Davis, MD, MSc, and Prabhakar Tripuraneni, MD.mp4\u003c\/li\u003e\n\u003cli\u003eQ\u0026amp;A Panel Discussion-David Lanfear, MD, MS, Sumeet Mitter, MD, and Julie Rosenthal, MD.mp4\u003c\/li\u003e\n\u003cli\u003eStrategies to Minimize Radiation-Induced Heart Disease-Prabhakar Tripuraneni, MD.mp4\u003c\/li\u003e\n\u003cli\u003eThe Spectrum of Myocarditis From COVID to Immune Therapy-Nicolas Palaskas, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTreatment of ATTR Amyloid Current Options-Julie Rosenthal, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTreatment of ATTR Amyloid The Emerging Landscape-Ronald Witteles, MD.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954289840226,"sku":"MED-AMB00367","price":5.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Scripps-5th-Annual-Scripps-Cardiomyopathy-and-Cardio-Oncology-Symposium-2022.jpg?v=1779370160","url":"https:\/\/meducourse.com\/products\/scripps-5th-annual-scripps","provider":"Meducourse","version":"1.0","type":"link"}